NC
OCUL icon

Nehal Chopra’s Ocular Therapeutix OCUL Stock Holding History

Nehal Chopra’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Sell
70,792
-117,983
-62% -$1.07M 0.22% 36
2026
Q1 		$1.6M Buy
+188,775
New +$1.8M 0.59% 22
2024
Q2 		– Sell
-115,000
Closed -$1.05M – 42
2024
Q1 		$1.05M Buy
+115,000
New +$816K 0.56% 30

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nehal Chopra's OCUL Position: Q2 2026 in Review

Nehal Chopra reduced its Ocular Therapeutix (OCUL) stake by 62% in Q2 2026, selling an estimated $1.07M and leaving 70,792 shares worth $695K. The position accounts for 0.22% of the portfolio, ranked #36.

Nehal Chopra first reported a position in OCUL in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.6M in Q1 2026. 260 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Nehal Chopra held 70,792 shares of Ocular Therapeutix worth $695K as of Q2 2026.
  • Nehal Chopra sold 117,983 Ocular Therapeutix shares in Q2 2026, an estimated $1.07M.
  • Ocular Therapeutix made up 0.22% of Nehal Chopra's portfolio in Q2 2026, its #36 holding.
  • Nehal Chopra first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 3 quarters since.
  • Nehal Chopra's Ocular Therapeutix position peaked at $1.6M in Q1 2026.
  • 260 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Ratan Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.